Brief: RA Capital Management Reports About 10% Passive Stake In Medicenna Therapeutics As Of April 30, 2024
10/05/2024 22:55
May 10 (Reuters) - Medicenna Therapeutics Corp
MDNA.TO :
* RA CAPITAL MANAGEMENT, L.P. REPORTS ABOUT 10% PASSIVE
STAKE IN
MEDICENNA THERAPEUTICS CORP AS OF APRIL 30, 2024 - SEC FILING
Source text for Eikon: ID:n0001104659-24-060023
Further company coverage: MDNA.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results